Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v3-EN | Version v1-EN | |
|---|---|---|
| Language | English | English |
| Date Updated (Changed) | Updated to: 2026-03-06 | Was: 2026-02-05 |
| Drug Identification Number | 02538431 | 02538431 |
| Brand name | ACETYLCYSTEINE SOLUTION USP | ACETYLCYSTEINE SOLUTION USP |
| Common or Proper name | ACETYLCYSTEINE SOLUTION USP | ACETYLCYSTEINE SOLUTION USP |
| Company Name | STERIMAX INC | STERIMAX INC |
| Ingredients | ACETYLCYSTEINE | ACETYLCYSTEINE |
| Strength(s) | 200MG | 200MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | ORAL INTRAVENOUS INHALATION | ORAL INTRAVENOUS INHALATION |
| Packaging size | 200 MG/ML 30 ML | 200 MG/ML 30 ML |
| Additional packaging sizes | ||
| ATC code | R05CB | R05CB |
| ATC description | EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR. | EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR. |
| Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
| Anticipated start date | 2026-02-03 | 2026-02-03 |
| Actual start date | ||
| Estimated end date (Changed) | Updated to: 2026-05-30 | Was: 2026-04-30 |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Product is available and on 100% preventative allocation at McKesson. Contract coverage is available. | Product is available and on 100% preventative allocation at McKesson. Contract coverage is available. |
| Health Canada comments |